期刊文献+

全自动ELISA系统检测抗线粒体M2抗体及临床意义 被引量:5

Automatic ELISA system for the detection of anti-mitochondrial M2 antibody and its clinical significance
下载PDF
导出
摘要 目的使用全自动酶联免疫吸附试验(ELISA)系统检测抗线粒体M2抗体并探讨其临床意义。方法收集267例血清样本,包括112例原发性胆汁性肝硬化患者(PBC)、77例乙型肝炎病毒(HBV)感染者和78名健康对照者血清样本,使用全自动ELISA系统检测抗线粒体M2抗体,评估该系统检测抗线粒体M2抗体的精密度和抗线粒体M2抗体的临床价值。结果全自动ELISA系统的精密度较好,批内和天间的变异系数(CV)均〈5%。PBC患者抗线粒体M2抗体的阳性率为89.3%(100/112),抗体浓度值以大于800 RU/m L为主(63%,71/112)。HBV感染者抗线粒体M2抗体的阳性率为5.2%(4/77),3例抗体浓度值在25~100 RU/mL之间,1例在100 RU/mL以上;健康对照组中抗线粒体M2抗体阳性率为5.1%(4/78),4例抗体阳性者抗体浓度值均在25~50 RU/mL之间。结论抗线粒体M2抗体ELISA检测的系统化保证了检验结果的稳定性,可为PBC的诊断和与其他肝病的鉴别诊断提供更有价值的实验室依据。 Objective To detect anti-mitochondrial M2 antibody by automatic enzyme-linked immunosorbent assay( ELISA) system and to investigate its clinical significance. Methods A total of 267 serum samples[( 112 samples from patients with primary biliary cirrhosis( PBC),77 samples from patients infected with hepatitis B virus( HBV) and 78 samples from healthy controls] were detected for anti-mitochondrial M2 antibody by automatic ELISA system. The precision and the clinical significance of detecting anti-mitochondrial M2 antibody were evaluated. Results The precision was good. The within-run and inter-day coefficients of variation( CV) were 〈 5%. The patients with PBC had positive rate 89. 3%( 100 /112) for anti-mitochondrial M2 antibody,usually in high levels( 〉 800 RU / m L,63%,71 /112). The positive rate of anti-mitochondrial M2 antibody was 5. 2%( 4 /77) in patients with HBV infection,including 3cases of 25-100 RU / m L and 1 case of 〉 100 RU / m L,and it was 5. 1%( 4 /78) in healthy subjects. Conclusions Automatic ELISA system for the detection of anti-mitochondrial M2 antibody guarantees the stability of results. It will provide valuable laboratory reference for the diagnosis of PBC and the differential diagnosis for other liver diseases.
出处 《检验医学》 CAS 2015年第12期1234-1237,共4页 Laboratory Medicine
基金 卫生计生委医药卫生科技发展研究中心资助项目(28-5-5)
关键词 抗线粒体M2抗体 原发性胆汁性肝硬化 酶联免疫吸附试验 Anti-mitochondrial M2 antibody Primary biliary cirrhosis Enzyme-linked immunosorbent assay
  • 相关文献

参考文献9

  • 1BOGDANOS DP, GERSHWIN ME. What is new in primary biliary cirrhosis [J]. Dig Dis, 2012, 30(Suppl 1): 20-31.
  • 2HIRSCHFIELD GM, GERSHWIN ME. The immunobiology and pathophysiology of primary biliary cirrhosis [J]. Annu Rev Pathol, 2013, 8:303-330.
  • 3LIASKOU E,HIRSCHFIELD GM, GERSHWIN ME. Mechanisms of tissue injury in autoimmune liver diseases[J]. Semin Immunopathol, 2014, 36(5): 553-568.
  • 4LINDOR KD, GERSHWIN ME, POUPON R, et al. Primary biliary cirrhosis [J]. Hepatology, 2009, 50(1) : 291- 308.
  • 5贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24. 被引量:3213
  • 6谭延国,闫惠平,高祖华.原发性胆汁性肝硬化中B细胞免疫的研究进展[J].临床肝胆病杂志,2014,30(5):400-404. 被引量:5
  • 7WANG L, WANG FS, CHANG C, et al. Breach of tolerance: primary biliary cirrhosis[J]. Semin Liver Dis, 2014, 34(3):297-317.
  • 8LI Y,WANG W, TANG L, et al. Chemokine(C-X-C m.png) ligand 13 promotes intrahepatic chemokine (C-X-C m.png) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis[J]. Hepatology, 2015, 61(6):1998-2007.
  • 9YANG Z, LIANG Y, QIN B, et al. Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population [J]. Clin Biochem, 2012, 45(3): 203-206.

二级参考文献17

共引文献3216

同被引文献22

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部